Abbott (ABT) ended the recent trading session at $134.92, demonstrating a +1.31% swing from the preceding day's closing price. The stock outperformed the S&P 500, which registered a daily loss of 1.71 ...

We recently published a list of the 10 Best Drug Stocks to Buy Now. In this article, we are going to take a look at where ...

Strategic Financial Concepts LLC purchased a new position in shares of Abbott Laboratories (NYSE:ABT – Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The ...

The latest trading day saw Abbott (ABT) settling at $133.17, representing a +0.79% change from its previous close.

This was the stock's third consecutive day of gains.

We recently published a list of the 10 Best Medical Device Stocks To Buy According to Hedge Funds. In this article, we are ...

His fears were that Abbott (NYSE:ABT) might pull the product entirely rather than risk further lawsuits—just like Johnson & ...

2025年2月12日，全球知名医疗保健公司雅培（Abbott Laboratories，股票代码：ABT）在美股市场上表现不佳，股价盘中下跌1.21%，报129.845美元/股，成交额达2760.61万美元。尽管公司的财务数据显示，其2024年总收入达到419.5亿美元，同比增长4.59%；归母净利润高达134.02亿美元，同比大幅增长134.18%。如此背景下，雅培的股价为何仍然承压？

Abbott Laboratories (NYSE:ABT – Get Free Report) was downgraded by equities researchers at StockNews.com from a “strong-buy” ...

Shares of Abbott Laboratories ABT rallied 1.50% to $132.13 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.24% to ...